Flurox

Flurox

Flurox Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

Prolonged use of a topical ocular anesthetic is not recommended.  It may produce permanent corneal
opacification with accompanying visual loss.  Avoid contamination - do not touch tip of sterile dropper
used to dispense solution to any surface.  Replace container closure immediately after using.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

For procedures requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent such as
tonometry, gonioscopy, removal of corneal foreign bodies and other short corneal or conjunctival procedures.

History

There is currently no drug history available for this drug.

Other Information

Flourescein Sodium and Benoxinate Hydrochloride Opthalmic Solution USP, 0.25%/0.4% is a disclosing agent with rapid anesthetic action of short duration.
Fluorescein Sodium is represented by the following structural formula:
FL01
Chemical Name: Spiro  [isobenzofuran-1  (3H),9'-[9H]  xanthene]-3-one,  3',6'  dihydroxy, disodium salt.
Benoxinate Hydrochloride is represented by the following structural formula:

FL02
Chemical Name: 2-(Diethylamino) ethyl 4-amino-3butoxybenzoate monohydrochloride.

Flurox Manufacturers


  • Ocusoft, Inc.
    Flurox (Fluorescein Sodium 2.5mg (0.25%), Benoxinate Hydrochloride 4mg (0.4%)) Solution [Ocusoft, Inc.]

Login To Your Free Account